التفاصيل البيبلوغرافية
| العنوان: |
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. |
| المؤلفون: |
Caduff, Nicole, McHugh, Donal, Murer, Anita, Rämer, Patrick, Raykova, Ana, Landtwing, Vanessa, Rieble, Lisa, Keller, Christian W., Prummer, Michael, Hoffmann, Laurent, Lam, Janice K. P., Chiang, Alan K. S., Raulf, Friedrich, Azzi, Tarik, Berger, Christoph, Rubic-Schneider, Tina, Traggiai, Elisabetta, Lünemann, Jan D., Kammüller, Michael, Münz, Christian |
| المصدر: |
PLoS Pathogens; 12/21/2020, Vol. 16 Issue 12, p1-1, 1p |
| مصطلحات موضوعية: |
TACROLIMUS, EPSTEIN-Barr virus, DISEASES, THERAPEUTICS |
| مستخلص: |
The following information is missing from the Funding statement: AKSC was supported by a HMRF grant (18170462). Reference 1 Caduff N, McHugh D, Murer A, Rämer P, Raykova A, Landtwing V, et al. (2020) Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. [Extracted from the article] |
|
Copyright of PLoS Pathogens is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder